The retooling of old cognitive tests as an interim step on the path to validating a next generation of neuropsychological paradigms and assays

Alzheimer's and Dementia

Volumn 9, Issue 1 SUPPL., 2013, Pages

  Snyder, Peter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; EDITORIAL; HIPPOCAMPUS; HUMAN; LEARNING; LEARNING TEST; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; SYMPTOM; VALIDATION PROCESS;

EID: 84873403180     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.12.005     Document Type: Editorial

References (17)

1. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
2. K.A. Ellis, Y.Y. Lim, K. Harrington, D. Ames, A.I. Bush, and D. Darby Decline in Cognitive Function over 18 Months in Healthy Older Adults with High Amyloid-β J Alzheimers Dis 2013 Jan 8 [Epub ahead of print]
3. B.C. Dickerson, and D.A. Wolk Alzheimer's Disease Neuroimaging Initiative: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults Neurology 78 2012 84 90
4. M. Ewers, P. Insel, W.J. Jagust, L. Shaw, J.Q. Trojanowski, and P. Aisen CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects Cerebral Cortex 22 2012 1993 2004
5. L.S. Wang, Y.Y. Leung, S.K. Chang, S. Leight, M. Knapik-Czajka, and Y. Baek Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease J Alzheimers Dis 31 2012 439 445
6. E. Westman, J.S. Muehlboeck, and A. Simmons Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion Neuroimage 62 2012 229 238
7. M.M. Mielke, O.C. Okonkwo, K. Oishi, S. Mori, S. Tighe, and M.I. Miller Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease Alzheimers Dement 8 2012 105 113
8. J.L. Woodard, M. Seidenberg, K.A. Nielson, J.C. Smith, P. Antuono, and S. Durgerian Prediction of cognitive decline in healthy older adults using fMRI J Alzheimers Dis 21 2010 871 885
9. P.J. Snyder, C.E. Jackson, R.C. Petersen, A.S. Khachaturian, J. Kaye, and M.S. Albert Assessment of cognition in mild cognitive impairment: a comparative survey Alzheimers Dement 7 2011 3338 3355
10. J.J. Gomar, M.T. Bobe-Bascaran, C. Conejero-Goldberg, P. Davies, and T.E. Goldberg Utility of combinations of biomarkers, cognitive markers and risk factors to predict conversion from mild cognitive impairment to Alzheimer's disease in patients in the Alzheimer's Disease Neuroimaging Initiative Arch Gen Psychiatry 68 2011 961 969
11. B.M. Jedynak, A. Lang, B. Liu, E. Katz, Y. Zhang, and B.T. Wyman A computational neurodegenerative disease progression score: method and results with the Alzheimer's Disease Neuroimaging Initiative cohort Neuroimage 63 2012 1478 1486
12. D. Darby, R.H. Pietrzak, J. Fredrickson, M. Woodward, L. Moore, and A. Fredrickson Intra-individual cognitive decline using a brief computerized cognitive screening test Alzheimers Dement 8 2012 95 104
13. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
14. E.K. Festa, R.Z. Insler, D.P. Salmon, J. Paxton, J.M. Hamilton, and W.C. Heindel Neocortical disconnectivity disrupts sensory integration in Alzheimer's disease Neuropsychology 19 2005 728 738
15. E.K. Festa, W.C. Heindel, and B.R. Ott Dual-task conditions modulate the efficiency of selective attention mechanisms in Alzheimer's disease Neuropsychologia 48 2010 3252 3261
16. D.M. Rentz, R.E. Amarigio, J.A. Becker, M. Frey, L.E. Olson, and K. Frishe Face-name associative memory performance is related to amyloid burden in normal elderly Neuropsychologia 49 2011 2776 2783
17. C.M. Stonnington, P.J. Snyder, J.G. Hentz, E.M. Reiman, and R.J. Caselli Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers J Clin Psychiatry 70 2009 1379 1384